Market Analysis: Global Chronic Disease Management Market
Global chronic disease management market is expected to rise to an estimated value of USD 14.80 billion by 2026, registering a healthy CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing levels of geriatric population resulting in higher prevalence of chronic diseases in patients globally along with the advancement in technologies associated with medical devices.
Market Definition: Global Chronic Disease Management Market
Chronic disease management is digital healthcare services that include in providing healthcare officials with educational insights to their patients, implementation of patient-specific and disease-specific treatment options and plans. These services are specifically designed for managing the chronic diseases and reducing their severity in patients.
- Increasing prevalence and awareness regarding the fatality of chronic diseases; this factor is expected to drive the growth of the market
- Increasing levels of integration of digitalization in healthcare systems and facilities; this factor is expected to drive the growth of the market
- Rise in the support provided by the governments for the adoption of technologies in healthcare management; this factor is expected to drive the market growth
- Restraint in adoption and obedience in following the treatment plants designed according to the need of their disease management; this factor is expected to restrain the growth of the market
- Lack of technically skilled professionals and workforce required for the management and maintenance of these diseases; this factor is expected to restrain the market growth
Segmentation: Global Chronic Disease Management Market
By Disease Type
- Cardiovascular Diseases (CVD)
- Chronic Obstructive Pulmonary Disorders (COPD)
By Service Type
- Consulting Service
- Implementation Service
- Educational Services
By Deployment Model
- Ambulatory Care Centers
- Hospitals, Physician Groups & Integrated Delivery
- Diagnostic & Imaging Centers
- Home Healthcare Agencies, Nursing Homes & Assisted Living Facilities
- Public Payers
- Private Payers
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East & Africa
Key Developments in the Market:
- In October 2018, cliexa, Inc. announced that they had acquired Preventive Technology Solutions Inc. (PTSI). This acquisition will help in the development and expansion of cliexa’s service offerings. cliexa, Inc. will focus on the development of health apps for primary care and family medicine physicians which are determining the risks in adolescent for sexual activities, abuse of substances and other issues.
- In July 2016, HealthCare at home announced that they had acquired Health Impetus Pvt. Ltd, this acquisition is expected to provide HealthCare at home in providing disease management services as well as providing various services to the pharmaceutical industry.
Competitive Analysis: Global Chronic Disease Management Market
Global chronic disease management market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of chronic disease management market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Chronic Disease Management Market
Few of the major competitors currently working in the global chronic disease management market are Allscripts; ScienceSoft USA Corporation; Siemens Healthcare Private Limited; EXL; cliexa, Inc.; MINES & Associates, Inc.; Mediware Information Systems; Pegasystems Inc.; HealthCare atHOME; Cognizant TriZetto Software Group, Inc.; IBM Corporation; Infosys Limited; Koninklijke Philips N.V.; AxisPoint Health; Medecision; i2i Systems; Epic Systems Corporation and ZeOmega.
Research Methodology: Global Chronic Disease Management Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.
The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
- Current and future of global chronic disease management market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)